Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Elena Pita Calandre, Universidad de Granada
ClinicalTrials.gov Identifier:
NCT00791739
First received: November 12, 2008
Last updated: December 1, 2014
Last verified: December 2014